Literature DB >> 18299935

Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis.

Cristina Semino-Mora1, Hui Liu, Thomas McAvoy, Carol Nieroda, Kimberley Studeman, Armando Sardi, Andre Dubois.   

Abstract

BACKGROUND AND AIMS: Pseudomyxoma peritonei (PMP) is characterized by peritoneal tumors arising from a perforated appendiceal adenoma or adenocarcinoma, but associated entry of enteric bacteria in the peritoneum has not been considered as a cofactor. Because Gram-negative organisms can upregulate MUC2 mucin gene expression, we determined whether bacteria were detectable in PMP tissues.
METHODS: In situ hybridization was performed on resection specimens from five control subjects with noninflamed, nonperforated, non-neoplastic appendix and 16 patients with PMP [six with disseminated peritoneal adenomucinosis (DPAM) and 10 with peritoneal mucinous carcinomatosis (PMCA)]. Specific probes were designed to recognize: (1) 16S rRNA common to multiple bacteria or specific to H. pylori; (2) H. pylori cagA virulence gene; or (3) MUC2 or MUC5AC apomucins. Specimens from one patient with PMCA were examined by ultrastructural immunohistochemistry. Bacterial density and apomucin expression were determined in four histopathological compartments (epithelia, inflammatory cells, stroma, and free mucus).
RESULTS: Enteric bacteria were detected in all specimens. Bacterial density and MUC2 expression were significantly (p < 0.05) higher in PMCA than in DPAM and controls and were highest in free mucin. MUC2 was also expressed in dysplastic epithelia and in associated inflammatory cells. MUC2 expression was significantly correlated with bacterial density.
CONCLUSIONS: Multiple enteric bacteria are present in PMP, and bacterial density and MUC2 expression is highest in the malignant form of PMP. Based on these observations, we propose that the bacteria observed in PMP may play a role in the mucinous ascites and perhaps promote carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299935      PMCID: PMC2570966          DOI: 10.1245/s10434-007-9778-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  40 in total

1.  IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo.

Authors:  K Dabbagh; K Takeyama; H M Lee; I F Ueki; J A Lausier; J A Nadel
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

2.  Gene cloning and sequencing of BmK AS and BmK AS-1, two novel neurotoxins from the scorpion Buthus martensi Karsch.

Authors:  Z D Lan; L Dai; X L Zhuo; J C Feng; K Xu; C W Chi
Journal:  Toxicon       Date:  1999-05       Impact factor: 3.033

3.  Preferential formation and decreased removal of cisplatin-DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA.

Authors:  O A Olivero; P K Chang; D M Lopez-Larraza; M C Semino-Mora; M C Poirier
Journal:  Mutat Res       Date:  1997-06-13       Impact factor: 2.433

4.  Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease.

Authors:  J D Li; A F Dohrman; M Gallup; S Miyata; J R Gum; Y S Kim; J A Nadel; A Prince; C B Basbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

5.  Detection of a vacuolating cytotoxin in stools from children with diarrhea.

Authors:  I Luzzi; A Covacci; S Censini; C Pezzella; D Crotti; M Facchini; A Giammanco; P Guglielmetti; C Piersimoni; M Bonamico; P Mariani; R Rappuoli; A Caprioli
Journal:  Clin Infect Dis       Date:  1996-07       Impact factor: 9.079

6.  Isolation of Helicobacter pylori from human faeces.

Authors:  J E Thomas; G R Gibson; M K Darboe; A Dale; L T Weaver
Journal:  Lancet       Date:  1992-11-14       Impact factor: 79.321

7.  Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".

Authors:  B M Ronnett; C M Zahn; R J Kurman; M E Kass; P H Sugarbaker; B M Shmookler
Journal:  Am J Surg Pathol       Date:  1995-12       Impact factor: 6.394

8.  Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production.

Authors:  M K Tummuru; T L Cover; M J Blaser
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Rimmed vacuoles with beta-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis.

Authors:  C Semino-Mora; M C Dalakas
Journal:  Hum Pathol       Date:  1998-10       Impact factor: 3.466

10.  Antigen unmasking for immunoelectron microscopy: labeling is improved by treating with sodium ethoxide or sodium metaperiodate, then heating on retrieval medium.

Authors:  J W Stirling; P S Graff
Journal:  J Histochem Cytochem       Date:  1995-02       Impact factor: 2.479

View more
  14 in total

1.  Centrosomal amplification and aneuploidy induced by the antiretroviral drug AZT in hamster and human cells.

Authors:  Jennifer P Borojerdi; Jessica Ming; Catherine Cooch; Yvona Ward; Cristina Semino-Mora; Mia Yu; Hannan M Braun; Barbara J Taylor; Miriam C Poirier; Ofelia A Olivero
Journal:  Mutat Res       Date:  2009-03-24       Impact factor: 2.433

Review 2.  Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Authors:  Traci L Testerman; James Morris
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 3.  New insights in the pathology of peritoneal surface malignancy.

Authors:  Norman John Carr
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 4.  Potential mucolytic agents for mucinous ascites from pseudomyxoma peritonei.

Authors:  Krishna Pillai; Javed Akhter; Terence C Chua; David L Morris
Journal:  Invest New Drugs       Date:  2012-02-23       Impact factor: 3.850

Review 5.  Pathology of Mucinous Appendiceal Tumors and Pseudomyxoma Peritonei.

Authors:  Veena Ramaswamy
Journal:  Indian J Surg Oncol       Date:  2016-03-19

6.  Pseudomyxoma Peritonei: A Case Report Diagnosed in a 47-Year-Old Woman with Chronic Pelvic Abdominal Pain and Appendicular Origin: Review of the Literature and Management.

Authors:  Francois Pugin; Jean Bouquet De Jolinière; Attila Major; Fathi Khomsi; Louis Guillou; Mathias Peter; Nordine Ben Ali; Bernhard Egger; Anis Feki
Journal:  Front Surg       Date:  2017-12-18

7.  Pulmonary metastasis from pseudomyxoma peritonei.

Authors:  Toshiyuki Kitai
Journal:  Gastroenterol Res Pract       Date:  2012-07-12       Impact factor: 2.260

8.  A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei.

Authors:  Jeremy J Gilbreath; Cristina Semino-Mora; Christopher J Friedline; Hui Liu; Kip L Bodi; Thomas J McAvoy; Jennifer Francis; Carol Nieroda; Armando Sardi; Andre Dubois; David W Lazinski; Andrew Camilli; Traci L Testerman; D Scott Merrell
Journal:  Orphanet J Rare Dis       Date:  2013-07-12       Impact factor: 4.123

Review 9.  Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects.

Authors:  Afshin Amini; Samar Masoumi-Moghaddam; Anahid Ehteda; David Lawson Morris
Journal:  Orphanet J Rare Dis       Date:  2014-05-05       Impact factor: 4.123

10.  A Novel Member of Chitinophagaceae Isolated from a Human Peritoneal Tumor.

Authors:  Alexander S Lo; D Scott Merrell; Haiyan Lei; Armando Sardi; Thomas McAvoy; Traci L Testerman
Journal:  Genome Announc       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.